Log in to save to my catalogue

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000086739

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

About this item

Full title

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

Publisher

Basel, Switzerland: Karger

Journal title

Dermatology (Basel), 2005-01, Vol.211 (2), p.174-187

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: Karger

More information

Scope and Contents

Contents

Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin condition that primarily affects children. Topical corticosteroids have been the mainstay of treatment since the late 1950s. While providing excellent short-term efficacy, topical corticosteroid usage is limited by potential adverse effects, including impairment of the f...

Alternative Titles

Full title

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1159_000086739

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000086739

Other Identifiers

ISSN

1018-8665

E-ISSN

1421-9832

DOI

10.1159/000086739

How to access this item